Aktieanalys

BioInvent: New Readout in Phase I/IIa trial of BI-1206 - Redeye

{newsItem.title}

Redeye Publicerad: 20 Apr 2023 09:29

Redeye comments on the new data presented by BioInvent from the intravenous arm of the study.

Länk till analysen i sin helhet: https://www.redeye.se/research/895521/bioinvent-new-readout-in-phase-i-iia-trial-of-bi-1206?utm_source=finwire&utm_medium=RSS

Nyheter om Bioinvent

Läses av andra just nu

Om aktien Bioinvent

Senaste nytt